Hyperlipidaemia and hypertension

Area of Science:

• Cardiology
• Internal Medicine
• Public Health

Background:

• Hyperlipidaemia and hypertension are prevalent risk factors for cardiovascular complications.
• Their combined presence significantly elevates cardiovascular risk, necessitating early identification and management.
• Effective treatment aims to mitigate serious health outcomes in high-risk individuals.

Purpose of the Study:

• To outline the importance of managing combined hyperlipidaemia and hypertension.
• To define target blood pressure and lipid levels for high-risk patients.
• To discuss therapeutic strategies for this patient group.

Main Methods:

• Review of current guidelines and therapeutic approaches for hypertension and hyperlipidaemia.
• Emphasis on non-pharmacological interventions such as weight reduction, dietary changes, smoking cessation, and increased physical activity.
• Discussion of pharmacological options, prioritizing antihypertensives with neutral lipid effects and bile acid sequestrants or HMG CoA reductase inhibitors for hypercholesterolaemia.

Main Results:

• Target blood pressure: diastolic < 90 mm Hg, systolic < 140 mm Hg.
• Target lipid levels: total cholesterol ≤ 200 mg/dl, LDL cholesterol ≤ 135 mg/dl, triglycerides ≤ 200 mg/dl.
• Non-pharmacological measures are the first line of treatment, followed by appropriate pharmacological interventions.

Conclusions:

• Integrated management of hyperlipidaemia and hypertension is essential for cardiovascular risk reduction.
• Lifestyle modifications are foundational, supplemented by pharmacotherapy when necessary.
• Careful drug selection is important to avoid adverse effects on lipid profiles.